UTO Y[au] - Search Results

Year	Number of Results
1986	1
1987	2
1989	1
1990	1
1991	2
1992	2
1994	2
1995	1
1996	1
1997	2
1998	2
1999	3
2000	12
2001	3
2002	12
2003	7
2004	6
2005	7
2006	11
2007	8
2008	7
2009	11
2010	10
2011	8
2012	10
2013	8
2014	13
2015	13
2016	19
2017	15
2018	15
2019	19
2020	13
2021	14
2022	5
2023	10
2024	7
2025	3

1

Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016-2020).

Ban HS, Uto Y, Nakamura H. Ban HS, et al. Among authors: uto y. Expert Opin Ther Pat. 2021 May;31(5):387-397. doi: 10.1080/13543776.2021.1874345. Epub 2021 Jan 29. Expert Opin Ther Pat. 2021. PMID: 33455469 Review.

2

Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).

Ban HS, Uto Y, Won M, Nakamura H. Ban HS, et al. Among authors: uto y. Expert Opin Ther Pat. 2016;26(3):309-22. doi: 10.1517/13543776.2016.1146252. Epub 2016 Feb 16. Expert Opin Ther Pat. 2016. PMID: 26882240 Review.

3

1,2-Benzisoxazole compounds: a patent review (2009 - 2014).

Uto Y. Uto Y. Expert Opin Ther Pat. 2015 Jun;25(6):643-62. doi: 10.1517/13543776.2015.1027192. Epub 2015 Mar 23. Expert Opin Ther Pat. 2015. PMID: 25800253 Review.

4

Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors.

Uto Y. Uto Y. Chem Phys Lipids. 2016 May;197:3-12. doi: 10.1016/j.chemphyslip.2015.08.018. Epub 2015 Sep 3. Chem Phys Lipids. 2016. PMID: 26344107 Review.

5

1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology.

Uto Y. Uto Y. Curr Pharm Des. 2016;22(21):3201-11. doi: 10.2174/1381612822666160224142648. Curr Pharm Des. 2016. PMID: 26907942 Review.

6

Implant-assisted removable partial dentures: Part I. a scoping review of clinical applications.

Kuroshima S, Ohta Y, Uto Y, Al-Omari FA, Sasaki M, Sawase T. Kuroshima S, et al. Among authors: uto y. J Prosthodont Res. 2024 Jan 16;68(1):20-39. doi: 10.2186/jpr.JPR_D_22_00252. Epub 2023 May 11. J Prosthodont Res. 2024. PMID: 37164658 Free article.

7

Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010).

Ban HS, Uto Y, Nakamura H. Ban HS, et al. Among authors: uto y. Expert Opin Ther Pat. 2011 Feb;21(2):131-46. doi: 10.1517/13543776.2011.547477. Epub 2011 Jan 6. Expert Opin Ther Pat. 2011. PMID: 21210751 Review.

8

Design of hypoxia-targeting drugs as new cancer chemotherapeutics.

Nagasawa H, Uto Y, Kirk KL, Hori H. Nagasawa H, et al. Among authors: uto y. Biol Pharm Bull. 2006 Dec;29(12):2335-42. doi: 10.1248/bpb.29.2335. Biol Pharm Bull. 2006. PMID: 17142959 Free article. Review.

9

Boron tracedrugs challenge for neutron dynamic therapy.

Hori H, Uto Y, Nakata E. Hori H, et al. Among authors: uto y. Anticancer Res. 2012 Jun;32(6):2235-9. Anticancer Res. 2012. PMID: 22641657 Review.

10

Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity.

Nagasawa H, Uto Y, Sasaki H, Okamura N, Murakami A, Kubo S, Kirk KL, Hori H. Nagasawa H, et al. Among authors: uto y. Anticancer Res. 2005 Nov-Dec;25(6A):3689-95. Anticancer Res. 2005. PMID: 16302727 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Results by year